3739
Phase 1 Studies Of MK-2214, A Novel Antibody Targeting pS413 Tau, For The Treatment Of Alzheimer’s Disease
Seth Robey, Jonathan Kurz, Kristine Cerchio, Zhiqing Xu, Jan de Hoon, An Bautmans, Kristien van Dyck, Kazuki Matsuda, Katsukuni Fujimoto, Arie Struyk
MSD, University Hospital Leuven
Poster Presenter: Seth Robey
